M&A Opportunity [SAFE]: Everglades Oysters

Why this is a differentiated asset: 1. Structural biological advantage. Tropical waters and year-round Everglades nutrient flow drive a 4–6 month grow-out cycle vs. 18–36 months for PEI, New England, and Pacific Northwest competitors. A 6x capital-to-product velocity that no U.S. competitor can replicate. 2. MSX-driven supply gap. MSX disease (Haplosporidium nelsoni) is projected to wipe out ~50% of Northeast crops — roughly $150M+ in at-risk annual production. Florida waters are MSX-free at 0% risk. We are positioned to absorb 4–5M lbs of displaced annual demand. 3. Distribution already built. 120+ active restaurant, resort, and retail accounts across six top-25 U.S. metros (15M+ consumers within same-day range). Owned cold-chain fleet (3 trucks). Product already on menus at Michelin-starred restaurants. 4. Farm unit economics. Farm-raised COGS of $0.30/oyster vs. $0.97 blended ASP = 69% gross margin, against 29% wholesale. Each $75 basket yields ~$194 in revenue per 6-month cycle (3.2x per-cycle return). Post-harvest inflection in November 2026 lifts monthly NOI from $15K to $63K. 5. 74-acre lease — largest off-bottom operation in the Gulf. Mechanized FlipFarm gear, 400K oysters/acre/yr capacity. 24-month forecast (Apr '26 – Mar '28): Fwd Revenue: Year 1- $5.89m; Year 2- $14.58m Fwd Net Op Income: Year 1- $346k; Year 2 - $4.64m Current raise (SAFE): • $1.25M - $2.00M SAFE on a $10M valuation cap (Prior SAFE: $955K from 8 investors) • Use of funds: $125K AP clearance, $125K operating reserve, $1.0M strategic reserve serving as collateral for $825K of 6%/7-year equipment debt • Capital structure is locked — the only variable from here is revenue, and Q1 validated the growth curve • Open to creative structures as well (i.e. independent sponsor economics) Please let me know if you wish to receive the CIM and model. Please email me at redacted or DM me here. Thank you, Ben